How Much is Too Much? As Congress seeks solutions to address drug prices, there has been some discussion about allowing Medicare to negotiate drug prices. Negotiation is a strategy that some foreign governments have used to control their healthcare costs. The drug price negotiation that occurs in other countries like Canada and the U.K. relies on a calculation called quality-adjusted

The Right Care at the Right Time in the Right Setting Delivering the right care to a patient at the right time in the right setting are key elements to successful outcomes. Unfortunately, all three of these elements may not be as accessible in some markets that have experience high rates of healthcare consolidation. Communities in which hospitals have merged,

COVID Can’t Stop the March of Discovery Over the past year, COVID-19 caused a lot in our world to slow down to what feels like a crawl. However, basic medical research in laboratories across the country continues to press forward. Basic research is what forms the foundation of translational discoveries – taking what’s learned in the lab to test new

Vaccine Protects More than Just You Health care workers are among the highest priority groups for the COVID-19 vaccine. For good reason. There’s broad agreement that their work on the front lines is closely associated with high exposure to the virus. Additionally, regions, cities and communities do not wish to lose access to medical care due to temporary provider shortages

It’s Time to Act on Delayed screening, Disregarded symptoms and Postponed treatment If you or a loved one delayed preventive screenings, disregarded signs and symptoms of an ailment or postponed treatment over the last year, it’s time to act. Don’t wait any longer to reconnect with your physician. Studies have confirmed that cancer screenings plummeted over the past year. Data

Celebrating 50 Years of Sustained Focus on Cancer This year we celebrate a milestone in cancer – the 50th anniversary of the National Cancer Act of 1971. An armada of resources, all trained on a single target, was set into motion in 1971. The Act created the nation’s clinical trials network. Those trials expanded treatments for cancer, reduced the toxicity